Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
6.87
+0.38 (5.86%)
At close: May 12, 2025, 4:00 PM
6.77
-0.10 (-1.46%)
After-hours: May 12, 2025, 5:18 PM EDT
Tempest Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Tempest Therapeutics stock have an average target of 30, with a low estimate of 9.00 and a high estimate of 65. The average target predicts an increase of 336.68% from the current stock price of 6.87.
Analyst Consensus: Hold
* Price targets were last updated on Apr 10, 2025.
Analyst Ratings
The average analyst rating for Tempest Therapeutics stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy → Hold Downgrades $91 → $9 | Buy → Hold | Downgrades | $91 → $9 | +31.00% | Apr 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $16 | Strong Buy → Hold | Downgrades | $16 | +132.90% | Apr 10, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $169 → $91 | Buy | Maintains | $169 → $91 | +1,224.60% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $611 → $208 | Strong Buy | Maintains | $611 → $208 | +2,927.66% | Mar 28, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $104 → $65 | Buy | Maintains | $104 → $65 | +846.14% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-15.19
from -19.50
EPS Next Year
-18.71
from -15.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -8.23 | -5.54 | -22.80 | ||
| Avg | -15.19 | -18.71 | -25.40 | ||
| Low | -20.00 | -25.59 | -27.54 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.